CIP treatment reduced the intestinal cell O157 infection, but increased the stx2-induced renal cell injury, whereas gentamicin treatment reduced both the intestinal cell O157 infection and stx2-induced renal cell injury. The gene discussed is STX2; the disease is hereditary sensory and autonomic neuropathy.